INTESTINAL SECRETION IS IMPORTANT in maintaining the liquidity of intestinal contents during digestion, which aids the mixing of digestive enzymes with the luminal contents. In addition, the liquid secreted in the crypts serves to flush the mucus produced in the crypts to the surface epithelium, where it protects and lubricates the mucosa. In most intestinal regions, Cl Ϫ has been thought to be the primary anion secreted, which induces liquid secretion isosmotically. Defective regulation of Cl Ϫ secretion underlies major intestinal pathophysiology ranging from diarrhea (hypersecretion of liquid) to cystic fibrosis (CF; hyposecretion of liquid).
Studies in the CF mouse have established that an absence of Cl Ϫ secretion is associated with crypt dilation, goblet cell hyperplasia, and intestinal obstruction (see Ref. 8 for review). In light of the Cl Ϫ channel functions described for the CF transmembrane conductance regulator (CFTR) and its apical membrane localization in gut epithelia, the data from the CF mouse have established CFTR as the major path for conductive Cl Ϫ exit across the enterocyte apical membrane during anion secretion.
Although the focus of much research has been on the apical Cl Ϫ channel (CFTR) responsible for intestinal secretion, the basolateral pathway(s) by which Cl Ϫ enters the cell has received less attention. The basolateral Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC1) is thought to play a key role as a Cl Ϫ entry pathway in intestinal epithelia (9, 11) to sustain Cl Ϫ secretion. In intestinal epithelia, NKCC1 electroneutrally transports Cl . The loop diuretics bumetanide and furosemide are effective blockers of NKCC1 and have been used to determine the contribution of the cotransporter to the secretory response of the intestine. However, a more specific strategy to identify the contribution of basolateral NKCC1 to the basal and stimulated Cl Ϫ secretion of the intestine is the use of gene targeting. In the present study, we have inactivated Slc12a2, the gene that codes for the NKCC1 cotransporter, and tested the intestinal epithelia of the mutant mice for the expression of a gut phenotype in Ussing chamber studies designed to identify the NKCC1 cotransporter contribution to basal and regulated anion secretion in two different regions of the mouse gastrointestinal tract.
MATERIALS AND METHODS
Adult animals (3-8 mo old) were used in this investigation. All mice were allowed food and water ad libitum until the time of the experiment. In all cases, homozygous normal littermates (referred to as ϩ/ϩ, normal, or wild-type) were compared with the NKCC1-deficient mice homozygous for mutant Slc12a2 (referred to as NKCC1 Ϫ/Ϫ). Two mutations in Slc12a2 were generated (20) , and mice bearing these mutations were studied. Ion-transport data for only one of the mutations (Slc12a2 ⌬1065-1137 ) are reported, because the physiological characterization of tissues from mice bearing the two mutations was identical. Mice carrying each mutation (not all mice studied were weighed) had a lower body mass than that of normal littermates [19. 7 Ϯ 1.2 and 29.9 Ϯ 1.8 g for Slc12a2 ⌬1065-1137 mice vs. normal littermates, re-spectively (n ϭ 6 for each group); 18.7 Ϯ 0.77 and 24.2 Ϯ 0.72 g for Slc12a2 ⌬506-621 mice vs. normal littermates, respectively (n ϭ 5 for each group)]. Mice were killed with CO 2 , and the intestine was quickly removed and placed in oxygenated Krebs buffer. The designated region of the intestine was opened lengthwise, flushed with buffer to remove intestinal contents, and then mounted on Ussing chambers having an exposed surface area of 0.25 cm 2 (7) . All preparations studied (ion transport and Northern analysis) were "full thickness" with the muscle layer and the enteric nervous system still intact. Tissues were studied under short-circuit current (I sc ) conditions for the duration of the experiment. A constant voltage pulse (1-5 mV, 1-s duration) was applied to the tissue every minute. Potential difference and resistance were calculated using Ohm's law from the changes in I sc in response to the voltage pulse. 3 Ϫ was removed from the medium, 10 Ϫ3 M acetazolamide was added to the buffer to prevent endogenous tissue HCO 3 Ϫ production. Where indicated, some preparations were treated with TTX (10 Ϫ6 M basolateral) to block neurotransmitter release from the enteric nervous system. All preparations contained 5 mM glucose in the basolateral solution and 5 mM mannitol in the apical solution.
Selected drugs were used to characterize the basolateral anion entry paths (see Fig. 9 ). Bumetanide, an inhibitor of NKCC1, was added to the basolateral bath to test for inhibition of the basal I sc or to test for inhibition of the forskolinstimulated current. The bumetanide sensitivity was calculated as the magnitude of change in I sc over a 4-min period after bumetanide addition. DIDS was used to block both Cl Ϫ /HCO 3 Ϫ exchange and Na ϩ -HCO 3 Ϫ cotransport. Dimethylamiloride (DMA) was used to block Na ϩ /H ϩ exchange. Hydrochlorothiazide, which blocks NaCl-coupled exchange (see Ref. 9 for review), was also tested in intestinal tissue. Drugs were used at the following concentrations (in M): 10 Ϫ4 bumetanide (basolateral), 10 Ϫ5 forskolin (bilateral), 10 Ϫ3 acetazolamide (bilateral), 10 Ϫ3 DIDS (basolateral), 10 Ϫ5 DMA (basolateral), 10 Ϫ4 hydrochlorothiazide (basolateral), and 10 Ϫ4 amiloride (apical). All drugs and chemicals were purchased from Sigma Chemical (St. Louis, MO) with the exception of DIDS, which was purchased from Molecular Probes (Eugene, OR).
Northern analysis. Total RNA was isolated from salivary and intestinal tract tissue of wild-type animals. Tissue was frozen, homogenized, and phenol/chloroform extracted using RNAzol B (Tel-test, Friendswood, TX). Total RNA (20 g) was electrophoresed on a 1.1% formaldehyde, 1.2% agarose denaturing gel in the presence of ethidium as described by Kroczek and Siebert (16) and transferred to Immobilon-NC nitrocellulose membrane (Millipore, Bedford, MA) by capillary transfer. Radiolabeled DNA probes were hybridized to Northern blots in Quick-Hybe (Stratagene) for 1 h at 68°C.
Histological analysis. Wild-type and Slc12a2 ⌬506-621 mice were killed, and intestinal tract tissues were fixed in 10% neutral-buffered formalin. The fixed tissues were embedded in paraffin, cut into 5-m sections, and stained with aniline blue and periodic acid-Schiff's reagent.
In situ analysis. A probe for in situ analysis was prepared in the following manner. The primers NKCC3a, 5Ј-CAG GGC CTG CTT TACTTCATCTTG-3Ј, and NKCC3b, 5Ј-GCC TTT CCG TGC GAC TGG-3Ј, were used to generate a 1.2-kb cDNA probe from salivary gland mRNA by RT-PCR. The fragment was cloned into pCR 2.1, the clone was digested with Hind III to remove a 700-bp fragment of cDNA, and this clone was religated to give a cDNA probe of ϳ600 bp corresponding to bases 3127 to 3636 of the published mouse NKCC1 sequence (18) . Using this construct, 35 S-labeled sense and antisense RNA was prepared (Maxiscript SP6/T7 kit; Ambion, Austin, TX) and used to analyze tissue sections prepared as follows. Tissues were fixed in 4% paraformaldehyde and washed with 30% sucrose in PBS to remove the fixative. Tissues were embedded in Tissue-Tek, and cryostat sections cut at 8 m were mounted on slides and stored at Ϫ80°C. Sections were fixed in 4% paraformaldehyde and dehydrated in a graded series of ethanol washes. Sections were then digested with proteinase K (10 g/ml) for 30 min at 30°C. Proteinase K was inactivated by addition of 4% paraformaldehyde, and the sections were rinsed in triethanolamine and acetylated with 0.25% acetic anhydride for 10 min. Sections were then rinsed in 0.2ϫ SSC (1ϫ SSC is 0.15 M NaCl and 0.015 M sodium citrate, pH 7.0) and dehydrated. A quantity of NKCC1 sense or antisense probe producing 1 ϫ 10 7 cpm was hydridized to the sections overnight at 54°C in 50% formamide, 1ϫ Denhardt's solution, 0.6 M NaCl, 10 mM Tris, pH 8.0, 1 mM EDTA, 0.1% SDS, 10 mM dithiothreitol (DTT), 1 mg/ml yeast transfer RNA, and 10% dextran sulfate. Slides were washed with 4ϫ SSC and treated with 20 g/ml RNase at 37°C, then washed four times with 2ϫ SSC and 1 mM DTT at room temperature and washed three times with 0.5ϫ SSC and 1 mM DTT at 54°C. Slides were dehydrated and hand-dipped in NTB2 emulsion (Eastman Kodak, Rochester, NY), exposed for 2 wk at 4°C, developed, and stained with hematoxylin and eosin.
Statistics. All data are means Ϯ SE. Only one preparation per animal (of each intestinal region) was studied for each protocol. Data were compared by a Student's t-test if only two groups were being compared. If more than two groups were compared, ANOVA was used and a Student-Newman-Keuls test was used for multiple comparisons among groups.
RESULTS

Expression of NKCC1 in mouse intestinal tract.
To examine the expression of Slc12a2 in the mouse intestinal tract, Northern analyses were carried out on RNA prepared from various regions of the intestinal tract of normal animals. Expression was detected in all regions examined; however, expression was higher in the distal regions, with the highest levels seen in the cecum and colon (Fig. 1A) . In situ analysis of a section from wild-type jejunum was performed to determine the expression pattern of the message for the Slc12a2 gene within this tissue. Slc12a2 expression was largely restricted to the epithelium lining the crypts (Fig. 1C) . No expression was detected in the muscle layers of the intestinal tract.
Neonatal death associated with intestinal obstruction is common in mice deficient in the CFTR gene, and the growth rate of the surviving pups is often lower than that of normal littermates (see Ref. 8 
for review).
No neonatal deaths were observed in the NKCC1 Ϫ/Ϫ mice in this study, in contrast with data previously described (5) . Mice deficient in NKCC1 were growth retarded, and the majority of these animals fail to reach the weight of littermates (20) . To determine whether loss of NKCC1 resulted in alterations in the intestinal epithelia, histological analysis was carried out on tissue from all regions of both neonates and adult NKCC1-deficient animals. As can be seen in Fig.  1, D and E, the intestinal epithelium was largely normal. Comparison with wild-type tissue did, however, reveal a slight increase in the frequency of dilated crypts in the NKCC1-deficient tissue.
Jejunum. Ion transport across a midjejunal region was characterized for mice carrying the Slc12a2 ⌬1065-1137 and Slc12a2 ⌬506-621 mutations. "Basal" refers to the I sc recorded 30 min after mounting. There were no significant differences in either the basal or stimulated I sc between the two Slc12a2 mutations and their respective controls. Therefore, only the jejunal data from the Slc12a2 ⌬1065-1137 jejuna (and littermate controls) are shown.
The basal bioelectric properties for the wild-type and Ϫ/Ϫ jejuna bathed in KBR (as well as 0 HCO 3 Ϫ and 0 Cl Ϫ ) are shown in Table 1 . When bathed in bilateral KBR, the jejuna from the Ϫ/Ϫ mice exhibited a net Values are means Ϯ SE of n preparations. I sc , short-circuit current; G t , tissue conductance; PD, potential difference; KBR, Krebs-HCO 3 Ϫ -Ringer. * P Ͻ 0.01 vs. Ϫ/Ϫ in respective buffer.
basal I sc that did not differ significantly from the control (ϩ/ϩ) jejuna ( Fig. 2A ; Table 1 ). The basal I sc (determined at the midpoint of the oscillations) of both the control and the Ϫ/Ϫ preparations exhibited spontaneous oscillations that have been previously characterized as oscillations in the basal rate of anion secretion mediated by neurotransmitter release from the enteric nervous system (Refs. 7 and 25; Fig. 3 , A and C). The magnitude of these oscillations was virtually identical for control and Ϫ/Ϫ mice ( Table 2 ). The basal I sc of the ϩ/ϩ jejuna exhibited a small decrease in response to basolateral bumetanide, whereas the basal I sc of the Ϫ/Ϫ jejuna was unresponsive to bumetanide ( Fig. 2B, KBR) . The bumetanide-insensitive basal I sc was similar for the two genotypes (Fig. 2B ). Bumetanide also significantly reduced the magnitude of the oscillations in the ϩ/ϩ preparation (see Ref. 7) but had no effect on the oscillations in the Ϫ/Ϫ preparations (data not shown). Interestingly, the transmembrane conductance in KBR was significantly greater in the Ϫ/Ϫ jejunum compared with the wild-type preparations ( Table 1) .
Most of the preparations in this investigation were studied as full-thickness preparations with the enteric nervous system intact. To determine the role of the enteric nervous system in maintaining the I sc in wildtype and Ϫ/Ϫ tissue, some preparations were treated basolaterally with TTX. In both the normal and Ϫ/Ϫ jejuna, TTX caused a significant decrease in the magnitude of the basal I sc but the post-TTX I sc did not differ between the genotypes (Fig. 4A) . The post-TTX conductance was again significantly greater in the Ϫ/Ϫ preparations (data not shown). The influence of bumetanide on the basal I sc was not studied in the TTX-treated preparations.
To identify potential routes for Cl Ϫ influx under basal conditions across the basolateral enterocyte membrane, the jejuna of NKCC1 Ϫ/Ϫ mice were studied using ion-substitution protocols. Bilateral Cl Ϫ replacement eliminated the spontaneous oscillations in the basal I sc of both the wild-type and the Ϫ/Ϫ jejuna ( Table 2 ). In bilateral Cl Ϫ -free buffer, net basal I sc was significantly and proportionately reduced in both genotypes ( Fig. 2A and Table 1 ), and tissues of neither genotype responded to bumetanide (Fig. 2B, 0 Cl Ϫ ). As in KBR, the conductance of the Ϫ/Ϫ preparations was significantly increased compared with the ϩ/ϩ tissue (Table 1) .
In another series of ion-substitution experiments, HCO 3 Ϫ was removed from the buffer bathing both tissue surfaces. HCO 3 Ϫ substitution had no significant effect on the magnitude of the net basal I sc in the control jejuna. However, this maneuver significantly reduced the magnitude of the I sc in the Ϫ/Ϫ jejuna compared with tissue incubated in KBR ( Fig. 2A and Table 1 ). In HCO 3 Ϫ -free buffer, the I sc of the ϩ/ϩ jejuna had a significantly greater response to bumetanide than did the ϩ/ϩ preparations in KBR (Fig. 2B) . The Ϫ/Ϫ tissue again was not inhibited by bumetanide in this buffer. Interestingly, bilateral removal of HCO 3 Ϫ significantly reduced the magnitude of the I sc oscillations in both the normal and Ϫ/Ϫ jejuna ( Table 2 ). The conductance was again significantly greater in the Ϫ/Ϫ tissue compared with the ϩ/ϩ preparations in HCO 3 Ϫ -free solutions (Table 1) .
A number of TTX-treated preparations were studied in bilateral HCO 3 Ϫ -free buffer. HCO 3 Ϫ -free buffer had no significant effect on the magnitude of the net basal I sc of the normal preparations (post-TTX) compared with normal TTX-treated preparations in KBR (Fig.  4A) . However, the post-TTX I sc in the Ϫ/Ϫ jejuna incubated in HCO 3 Ϫ -free buffer was significantly reduced (3-fold) compared with the TTX-treated Ϫ/Ϫ jejuna incubated in KBR (Fig. 4A) .
Removal of both HCO 3 Ϫ and Cl Ϫ bilaterally from the solutions bathing the tissues caused a significant reduction in the magnitude of the I sc of the normal tissue (compared with tissue in KBR and HCO 3 Ϫ -free KBR but not Cl Ϫ free alone) but did not significantly reduce the magnitude of the I sc in the Ϫ/Ϫ tissue compared with tissues incubated in bilateral HCO 3 Ϫ -or Cl Ϫ -free medium ( Fig. 2A) . We did not test the effect of bumetanide on the basal I sc of these tissues. However, because bumetanide had no effect on the basal I sc in the bilateral Cl Ϫ -free group, this drug would not be expected to have an effect on this group of tissues.
We also used selected drugs to test for other transport paths that could account for basolateral anion influx in wild-type and mutant jejunal epithelia. In the normal jejunum, basolateral DIDS caused a large transient increase in I sc [⌬ ϭ 65.7 Ϯ 2.7 A/cm 2 (n ϭ 7)] (Fig. 3B) . After DIDS application, the oscillations in the basal I sc tended to be somewhat smaller than the magnitude of the pre-DIDS oscillations; however, this difference was not significant, and DIDS had no detectable effect on basal I sc [56.6 Ϯ 7.1 vs. 65.5 Ϯ 4.4 A/cm 2 for pre-vs. post-DIDS (5 min); Fig. 3B ]. In contrast, in the NKCC1 Ϫ/Ϫ jejuna, basolateral DIDS caused a small, transient (2-3 min) increase in the I sc (Fig. 3D) . Three to five minutes after DIDS application, the oscillations in the basal I sc disappeared (n ϭ 5) (Fig. 3D) , and the magnitude of the basal I sc was significantly reduced [74.1 Ϯ 16 vs. 45.3 Ϯ 7.9 A/cm 2 for pre-vs. post-DIDS (n ϭ 5 for both); PՅ0.05].
Mice with mutant NKCC1 exhibited major differences from wild-type mice in response to cAMP-stimulated Cl Ϫ secretion. In KBR buffer, the jejuna of the Ϫ/Ϫ mice responded to forskolin with an increase in I sc that was markedly reduced compared with the forskolin response exhibited by the normal jejuna (Fig. 3 , A and C, and Fig. 5A , KBR data). In the ϩ/ϩ tissue, virtually the entire forskolin response was inhibited by bumetanide, whereas the forskolin response of the Ϫ/Ϫ jejuna exhibited no significant response to bumetanide (Fig. 3, A and C, and Fig. 5B, KBR data) .
In TTX-treated preparations bathed in KBR, the magnitude of the forskolin response was also significantly reduced in the Ϫ/Ϫ jejuna (Fig. 4B) . Bumetanide again inhibited the forskolin response in the TTXtreated normal preparations but had no effect on the forskolin response in the TTX-treated Ϫ/Ϫ jejuna (Fig.  4C) . However, in the normal TTX-treated preparations a small bumetanide-insensitive forskolin-stimulated I sc was present (Fig. 4C ) that was significantly less than the bumetanide-insensitive response of the Ϫ/Ϫ 
Values are means Ϯ SE of n preparations (given in parentheses). NKCC1, Na ϩ -K ϩ -2Cl Ϫ cotransporter; bilat, bilateral; basolat, basolateral.
tissue, a pattern similar to the forskolin tissues without TTX pretreatment (Fig. 5B) .
The response to forskolin was significantly reduced by bilateral Cl Ϫ removal in normal tissue, whereas this maneuver had no significant effect on the magnitude of the forskolin response in the Ϫ/Ϫ jejuna (Fig. 5A) . In normal tissue, this was caused by the elimination of the bumetanide-sensitive component of the forskolin response (Fig. 5B) . Removal of HCO 3 Ϫ from the medium had no effect on the magnitude of the forskolin response in the normal jejuna, which was 100% inhibitable by bumetanide (Fig. 5) . However, this maneuver significantly reduced the magnitude of the forskolin response (bumetanide insensitive) in the Ϫ/Ϫjejuna compared with tissue incubated in KBR (Fig. 5) . Ϫ -free buffer in the ϩ/ϩ preparations was unchanged from that in KBR, whereas the Ϫ/Ϫ jejuna exhibited a significantly attenuated response (Fig. 4B) . The normal preparations (0 HCO 3 Ϫ post-TTX) exhibited a marked bumetanide sensitivity after forskolin (virtually 100% bumetanide sensitive), whereas the Ϫ/Ϫ preparations did not respond to bumetanide (Fig. 4C) .
The forskolin responses of both genotypes were significantly attenuated in Cl Ϫ -free/HCO 3 Ϫ -free buffer compared with the responses exhibited by the tissues in KBR (Fig. 5A) . In Cl Ϫ -free/HCO 3 Ϫ -free buffer, the entire forskolin-stimulated I sc was bumetanide insensitive in both groups (Fig. 5B ). An additional group of Ϫ/Ϫ jejunal preparations was studied in basolateral Na ϩ -free buffer and exhibited no significant response to forskolin (⌬I sc ϭ 6 Ϯ 2.7 A/cm 2 ; n ϭ 4). Another series of experiments was conducted on jejuna from Ϫ/Ϫ mice in which only basolateral Cl Ϫ or HCO 3 Ϫ was replaced. The data from these experiments did not differ significantly from those obtained from the bilateral solution replacement studies (data not shown).
The magnitude of the forskolin response in DIDSpretreated tissues (serosal) did not differ significantly from tissue not pretreated with serosal DIDS in either genotype [ϩ/ϩ: ⌬I sc with no DIDS treatment 51.7 Ϯ 8.1 A/cm 2 (n ϭ 10) vs. ⌬I sc with DIDS pretreatment 50.0 Ϯ 9.7 A/cm 2 (n ϭ 7); Ϫ/Ϫ: ⌬I sc with no DIDS treatment 19.2 Ϯ 3.8 A/cm 2 (n ϭ 10) vs. ⌬I sc with DIDS pretreatment 19.8 Ϯ 4.4 A/cm 2 (n ϭ 4)]. When DIDS was applied after forskolin and bumetanide (in KBR) in the normal preparations, the DIDS response did not differ significantly from zero (7.2 Ϯ 4.4 A/cm 2 ; n ϭ 4). In contrast, DIDS caused a significant inhibition in the stimulated I sc in the Ϫ/Ϫ preparations (Ϫ19.4 Ϯ 4.5 A/cm 2 ; n ϭ 4). In both control and Ϫ/Ϫ jejuna, the forskolin increase in I sc was insensitive to serosal DMA (10 Ϫ5 M) and hydrochlorothiazide (10 Ϫ4 M) (data not shown; both applied after forskolin). Cecum. In contrast to the jejuna, the ceca of the NKCC1 Ϫ/Ϫ mice exhibited basal I sc that were significantly reduced compared with those of ceca from normal mice (Fig. 6 and Table 3 ). Amiloride (10 Ϫ4 M, mucosal) had no significant effect on the magnitude of the basal I sc in either the normal or Ϫ/Ϫ tissue (data not shown). Bumetanide caused a 34 Ϯ 2.9% inhibition of basal I sc in the ϩ/ϩ ceca, whereas in the Ϫ/Ϫ ceca, bumetanide had no significant effect on basal I sc (5.6 Ϯ 5.6% increase in basal I sc ). The bumetanide-insensitive I sc in the ϩ/ϩ tissue (55.9 Ϯ 15 A/cm 2 , n ϭ 4) was significantly greater than that in the Ϫ/Ϫ tissue (P Ͻ 0.05). Interestingly, unlike the jejuna, in the ceca there was no significant difference in the transepithelial conductance between the two genotypes ( Table 3) .
Incubating normal ceca in bilateral Cl Ϫ -free buffer significantly decreased the basal I sc , whereas this maneuver did not change the basal I sc of the Ϫ/Ϫ tissue (Fig. 6 ). The effect of bumetanide on the basal I sc was studied only in preparations incubated in KBR. Incubating normal ceca in bilateral HCO 3 Ϫ -free buffer significantly reduced basal I sc compared with KBR (Fig.  6 ). This maneuver did not significantly reduce the magnitude of I sc in the Ϫ/Ϫ ceca. Removing both Cl Ϫ and HCO 3 Ϫ bilaterally from the medium reduced the magnitude of basal I sc in the normal tissue compared with tissue incubated in KBR (Fig. 6) . In this buffer, the basal I sc of the Ϫ/Ϫ ceca was small (only ϳ9.4 A/cm 2 ) and was significantly different from the basal I sc in KBR.
Interestingly, the magnitude of the forskolin response in the Ϫ/Ϫ ceca did not differ significantly from that of the ϩ/ϩ ceca (Fig. 7A, KBR data) . However, bumetanide inhibited most of the forskolin response in the normal ceca but had no significant effect on the response of ceca from the Ϫ/Ϫ mice (Fig. 7B, KBR  data) ; thus the bumetanide-insensitive I sc was significantly elevated in the Ϫ/Ϫ tissue (KBR) compared with normal preparations (Fig. 7B) .
Ion-substitution studies were again carried out in an attempt to further characterize the response to forskolin in these tissues. Bilateral Cl Ϫ -free buffer significantly reduced the magnitude of the forskolin response in tissues of both genotypes compared with the respective tissues incubated in KBR (Fig. 7A) . Neither tissue responded to bumetanide (postforskolin) in Cl Ϫ -free buffer (Fig. 7B) ; therefore, the magnitude of the bumet- anide-insensitive forskolin responses was nearly identical in this buffer (Fig. 7B ). The forskolin response was similar to control (KBR) in normal ceca in bilateral HCO 3 Ϫ -free buffer, and the ratio of the bumetanide-sensitive vs. bumetanide-insensitive response was similar to that of the ϩ/ϩ tissues in KBR (Fig. 7) . However, in the Ϫ/Ϫ ceca, the magnitude of the forskolin response was significantly reduced in bilateral HCO 3 Ϫ -free buffer compared with KBR (Fig. 7A) . The Ϫ/Ϫ ceca incubated in bilateral HCO 3 Ϫ buffer again did not respond to bumetanide (Fig. 7B) . The bumetanide-insensitive I sc was significantly greater in the Ϫ/Ϫ preparations compared with the bumetanide-insensitive I sc of the normal preparation incubated in the buffer. The effect of bilateral HCO 3 Ϫ -free buffer on the magnitude of the forskolin response in TTX-treated ceca was also investigated. The responses of these preparations were similar to those of ceca not pretreated with TTX [forskolin response, HCO 3 Ϫ free, TTX treated ϩ/ϩ⌬I sc , 137.4 Ϯ 17 A/cm 2 (n ϭ 4) vs. Ϫ/Ϫ, 31.9 Ϯ 2.1 A/cm 2 (n ϭ 4); pՅ0.001; compare with data in Fig. 7A] .
When both Cl Ϫ and HCO 3 Ϫ were removed bilaterally from the medium, the forskolin response was very small and did not differ between the two genotypes (Fig. 7A) . Neither tissue responded to bumetanide when incubated in this buffer (Fig. 7B) .
In some preparations (KBR) DIDS was added after forskolin/bumetanide. DIDS caused a significant decrease in the magnitude of the forskolin-stimulated I sc in the Ϫ/Ϫ ceca only (30.6 Ϯ 7.9 A/cm 2 ; n ϭ 4; P Ͻ 0.05).
Removal of both HCO 3 Ϫ and Na ϩ from the basolateral side of the Ϫ/Ϫ ceca (HCO 3 Ϫ was also removed from the mucosal side to ensure that no HCO 3 Ϫ was transported across the tissue) caused no further attenuation in the forskolin response compared with HCO 3 Ϫ removal alone (Fig. 8) . The forskolin response of the Ϫ/Ϫ ceca in this buffer was not sensitive to DIDS (data not shown). However, when Cl Ϫ was also removed from the basolateral side of the tissue (in addition to the above ions), the forskolin response was significantly decreased (Fig.  8) .
DISCUSSION
We found that NKCC1 (encoded for by the Slc12a2 gene) mRNA expression was very prominent in the salivary gland and the more distal regions of the intestinal tract (Fig. 1) . The Na
Ϫ cotransporter is located in the basolateral membrane of many secretory epithelial cell types. Although the cotransporter is thought to play a role in basal and stimulated Cl Ϫ secretion by transporting Cl Ϫ across this barrier (Fig.  9) , the basolateral (and apical) membranes of many types of epithelial cells also may contain Cl , n ϭ 5 and 4 for normal and NKCC1 Ϫ/Ϫ, respectively; in 0 Cl Ϫ /0 HCO 3 Ϫ , n ϭ 4 for both genotypes. B: effect of bumetanide on the forskolin-stimulated I sc in ceca. Open bars, bumetanide-sensitive component of the forskolin-stimulated I sc in ϩ/ϩ jejuna; hatched bars, bumetanide-insensitive I sc in ϩ/ϩ preparations; solid bars, bumetanide-insensitive I sc in the Ϫ/Ϫ jejuna. **PՅ0.01 bumetanide-sensitive forskolin response in ϩ/ϩ tissue vs. bumetanide-sensitive forskolin response (ϭ 0) in Ϫ/Ϫtissue in same buffer; ϩϩ P Յ0.05 vs. bumetanide-insensitive forskolin response in ϩ/ϩ; §P Յ0.01 vs. bumetanide-insensitive response in KBR for Ϫ/Ϫ; *PՅ0.05 vs. respective genotype in KBR (bumetanideinsensitive I sc ). In KBR, n ϭ 10 for both genotypes; in 0 Cl Ϫ , n ϭ 5 and 4 for normal and NKCC1 Ϫ/Ϫ, respectively; in 0 HCO 3 Ϫ , n ϭ 4 for both genotypes; in 0 Cl Ϫ /0 HCO 3 Ϫ , n ϭ 4 for both genotypes.
Cl Ϫ in exchange for HCO 3 Ϫ (Fig. 9) . Na ϩ -HCO 3 Ϫ (NBC)-coupled entry has also been identified on the basolateral membrane of some intestinal epithelia, which can mediate a HCO 3 Ϫ contribution to intestinal anion secretion.
The NKCC1-deficient mutant mice do not die of intestinal obstruction and rupture either in the early prenatal period or as adult mice (20) . They thus differ from CF mice, which have a mutation in the CFTR gene that mediates apical membrane Cl Ϫ translocation, and typically exhibit severe intestinal pathophysiology resulting in both neonatal and adult mortality (3, 28) . A study was recently published on another NKCC1-deficient mouse model consistent with our finding that there was no increased death rate in neonatal NKCC1 Ϫ/Ϫ pups (5). However, unlike our study, Flagella et al. (5) reported a relatively high death rate (28%) of the NKCC1 Ϫ/Ϫ mice in the periweaning period. Although no definite cause of death was given, intestinal bleeding was noted in some pups (5). Whereas CF mice, which are deficient in apical membrane Cl Ϫ channel activity, exhibited dilated mucusfilled crypts and intestinal goblet cell hypertrophy and hyperplasia (8) , the NKCC1 Ϫ/Ϫ mice exhibited only very mild intestinal histopathology in the form of scattered dilated crypts that did not appear to contain mucus (Fig. 1, D and E) . In CF mice, the intestinal morbidity and high rate of prenatal mortality appear to result from the inability of the intestinal tract to secrete either Cl Ϫ or HCO 3 Ϫ in the basal or stimulated state (2, 7, 12, 24) . Because our NKCC1 Ϫ/Ϫ mice exhibit little intestinal histopathology and no obvious morbidity or mortality related to intestinal problems, it seems likely that the intestinal tracts of these animals are capable of sufficient liquid secretion to circumvent the intestinal problems that characterize the CF mice. We therefore characterized the anion transport paths that likely mediate liquid secretion in these animals.
Jejunum. Flux studies as well as ion-replacement studies (7, 25) suggest that a large part of the basal I sc in the normal mouse jejunum reflects Cl Ϫ secretion or is Cl Ϫ dependent (7, 25) . In our study, the basal I sc was insensitive to bumetanide in both the ϩ/ϩ and Ϫ/Ϫ jejuna and was of nearly identical magnitude in these genotypes. Blocking neurotransmitter release from the enteric nervous system (TTX-treated tissue) did not appear to alter this relationship. However, Cl Ϫ is clearly involved in the maintenance of the basal I sc , because removal of Cl Ϫ from the bathing medium significantly reduced the basal I sc similarly in both genotypes.
It is well established (2, 7, 15, 24, 25) that the normal murine intestine is capable of substantial electrogenic HCO 3 Ϫ secretion under both basal and stimulated conditions. Studies have identified an NBC coupled cotransport entry path at the basolateral membrane of enterocytes of several species (Refs. 1, 17; Fig. 9 ). The NBC has been found to be electrogenic with the usual stoichiometry being 1:2 or 1:3 (23) . In addition, the NBCs (there may be a number of isoforms, see Ref. 23 for details) are Na ϩ dependent, HCO 3 Ϫ dependent, and usually blocked by stilbenes such as DIDS (23) . It should be pointed out that some studies have failed to detect this basolateral cotransporter in intestine (10) .
HCO 3 Ϫ removal significantly decreased the magnitude of the bumetanide-insensitive I sc in both genotypes. In addition, in the ϩ/ϩ jejuna, this protocol significantly increased the bumetanide-sensitive component of the basal I sc , leaving the net I sc unchanged. This observation lends support to previous reports that removal of one of the anions (HCO 3 Ϫ ) from the buffer increased the secretion of the other (Cl Ϫ ) (17, 25) . In both ϩ/ϩ and Ϫ/Ϫ jejuna, one could speculate that in KBR at least part of the basal bumetanide insensitive I sc may be mediated by NBC basolateral entry. In the NKCC1 Ϫ/Ϫ tissue, the criteria for assigning NBC a role in basal transport appear to be met in that the basal I sc was electrogenic, Na ϩ dependent (see Table  2 ), HCO 3 Ϫ dependent, and at least partially sensitive to DIDS. In the Ϫ/Ϫ jejuna, DIDS completely eliminated the spontaneous oscillations in the basal I sc as well as decreasing the magnitude of the basal I sc . An inhibitory effect of DIDS on the NBC and or AE would be compatible with this observation. If the bumetanideinsensitive I sc in either genotype is due at least in part to HCO 3 Ϫ secretion, then why is the I sc diminished by Cl Ϫ removal? An interesting study on isolated colonic crypts reported that basolateral Cl Ϫ removal significantly attenuated the magnitude of the stimulated rate of HCO 3 Ϫ secretion in these preparations (6) . In pancreatic cells, it has been suggested that Cl Ϫ secretion maintains the driving force for basolateral NBC entry by depolarization of the membrane (26) . If this mechanism is operating in the jejuna under the conditions of our study (either or both ϩ/ϩ and Ϫ/Ϫ), basolateral Cl Ϫ entry would have to be via a non-NKCC1 pathway (see Fig. 9 ). Another possibility is that a parallel operation of a basolateral NBC and AE may been involved. In this scenario, HCO 3 Ϫ taken up via the NBC would be recycled across the basolateral membrane via the AE. Thus net electrogenic Cl Ϫ secretion would result. Either or both of these possibilities would explain the need for all three ions (Na ϩ , Cl Ϫ , and HCO 3 Ϫ ; Table 2 ). Interestingly, the transepithelial conductance of the NKCC1 Ϫ/Ϫ jejuna was significantly greater than that of the normal preparations in every buffer studied. The reason for this result is not known. As Ͼ80% of the transepithelial conductance of intestinal epithelia has been attributed to the paracellular pathway, the increased conductance most likely reflects a change in the conductance of this pathway (see Ref. 21 for discussion). It has been shown that when intestinal cells are stimulated to secrete, there is up to a 50% decrease in conductance (21) . It has been suggested that this change reflects cell swelling, which in turn reduces the width of the intracellular space, thus decreasing conductance (21) . If NKCC1 played a role in cell volume and the volume of the NKCC1 Ϫ/Ϫ cells was decreased compared with normal (unstimulated) cells, this difference theoretically might increase the transepithelial conductance. In our normal intestine, bumetanide (before forskolin) had no significant effect on the transepithelial conductance (data not shown). Therefore, at least on an acute basis, blocking the NKCC1 pathway in normal jejuna does not increase transepithelial conductance. Further study will thus be necessary to explain the difference in the transepithelial conductance across the jejuna of the two genotypes.
Removing both Cl Ϫ and HCO 3 Ϫ from the medium did not further diminish the magnitude of the basal I sc in Ϫ/Ϫ jejuna compared with the I sc when either anion was present. The origin of the I sc in bilateral Cl Ϫ / HCO 3 Ϫ -free medium in the ϩ/ϩ and Ϫ/Ϫ jejuna is not known. It would not be expected to be amiloride-sensitive Na ϩ absorption because this transporter is not present in jejunal tissue. Also, because there was no apical glucose present, electrogenic Na ϩ -glucose cotransport could not explain the basal I sc .
In the jejunum of the normal mouse, forskolin induced an increase in I sc that was Cl Ϫ dependent. The inhibition of the forskolin response by bumetanide, the marked decrease in the magnitude of this response when tissues were incubated in bilateral Cl Ϫ -free buffer, and the failure of bilateral HCO 3 Ϫ -free buffer to change the magnitude of this response support the speculation that the forskolin response reflects Cl Ϫ secretion. Therefore, NKCC1 appears to play a major role in the forskolin-stimulated response in this tissue.
It is interesting to note that there is a significant bumetanide-insensitive response to forskolin in the normal preparations in 0 Cl Ϫ buffer (12.4 Ϯ 4.2 A/ cm 2 ) and that this response did not differ in magnitude from the Ϫ/Ϫ jejuna in the same buffer. It is likely that the same basolateral entry mechanism supports the bumetanide-insensitive forskolin response in 0 Cl Ϫ buffer in normal and Ϫ/Ϫ jejuna.
The forskolin response was significantly reduced in the jejuna of the NKCC1 Ϫ/Ϫ mutant mice and was bumetanide insensitive. The Ϫ/Ϫ jejunal forskolin response in TTX-treated tissues was also significantly reduced compared with normal TTX-treated tissue (KBR). In a recent study on another NKCC1-deficient mouse model, some intestinal ion-transport data were reported (5). Flagella et al. (5) also noted a reduced response to forskolin (bumetanide insensitive) in the NKCC1 Ϫ/Ϫ jejunum. In our investigation, removal of Cl Ϫ from the bathing solution did not alter the magnitude of the response. Therefore, basolateral Cl Ϫ entry via a Cl Ϫ /HCO 3 Ϫ exchanger does not appear to play a role in the forskolin response. Removal of HCO 3 Ϫ from the buffer of the NKCC1 Ϫ/Ϫ jejunum, however, did significantly decrease the magnitude of this response to forskolin. In addition, removal of basolateral (but not apical) Na ϩ completely eliminated the forskolin response in the Ϫ/Ϫ tissue. These data suggest that the forskolin response by the NKCC1 Ϫ/Ϫ jejuna is dependent on basolateral Na ϩ /HCO 3 Ϫ entry. If at least a portion of the basal I sc and the forskolin response are due to HCO 3 Ϫ secretion, it is not readily apparent why the basal I sc is Cl Ϫ dependent whereas the forskolin response is not. Interestingly, in the rabbit mandibular gland, when Cl Ϫ secretion was blocked, HCO 3 Ϫ was able to support salivary secretion, but at a reduced rate (19) . Novak and Young (19) suggest that the lower rate of HCO 3 Ϫ secretion was due only to the anion being at a lower concentration than Cl Ϫ . There is much variability in the literature regarding the ability of DIDS to block Cl Ϫ /HCO 3 Ϫ (14, 29) and Na ϩ -HCO 3 Ϫ (4, 22, 27) entry pathways in the intestine. Interestingly, one study found that DIDS blocked the vasoactive intestinal polypeptide-or PGE 2 -stimulated HCO 3 Ϫ secretion in the rabbit duodenum, but when HCO 3 Ϫ secretion was induced with dibutyryl-cAMP the HCO 3 Ϫ secretory response was no longer sensitive to DIDS (31) . In our jejunal preparations incubated in KBR, basolateral DIDS applied after bumetanide and forskolin was without effect in the ϩ/ϩ tissue but significantly inhibited the forskolin response in the Ϫ/Ϫ jejuna. Interestingly, DIDS applied before forskolin was without effect on the magnitude of the forskolin response in either genotype. The reason for these differences is unknown. However, the data obtained when DIDS was applied after forskolin support the ion-substitution studies that suggest that the basolateral NBC may play a role in the stimulated secretory response in the Ϫ/Ϫ jejuna.
Cecum. The normal ceca exhibited a significantly greater net basal I sc than did the Ϫ/Ϫ tissue. This difference was primarily due to the significant bumetanide-sensitive component of the basal I sc in the normal cecum, which was absent in the normal jejunum. In addition, because removal of either Cl Ϫ or HCO 3 Ϫ significantly reduced the net I sc in the normal ceca, it is likely that the basal I sc in this region may reflect a combination of HCO 3 Ϫ basolateral entry (probably by NBC) and Cl Ϫ secretion, basolateral entry via NKCC1.
